Development and Validation of RP-HPLC Method for Oral Printed Films of Ketorolac Tromethamine
DOI:
https://doi.org/10.22270/ajprd.v10i5.1170Keywords:
Ketorolac Tromethamine, RP-HPLC Method, PDA detector.Abstract
For the analysis of Ketorolac Tromethamine in Oral film formulation, a simple, precise, and accurate method was developed and validated. On a Kromosil C18 column (150 cm 4.6 mm 5), an isocratic HPLC analysis was performed. The chemical was isolated using a solution of A 55:45 V/V methanol and ammonium dihydrogen phosphate buffer with a pH of 3.0 was used. Adjusted with 1.5 mL/min flow of O-phosphoric acid as the mobile phase UV detection was carried out. Photo diode array detection was used at 314 nm. The retention time was discovered to be 6.08 minutes. The system suitability criteria, such as theoretical plate count, tailing, and percentage, should be kept to a minimum. The RSD between six standard injections was within the acceptable range. The procedure was tested and found to be valid. According to the ICH guidelines over the concentration range of 50-150 gm/L, calibrations were linear. The correlation coefficient (r) of 0.999 indicates this. The method's resilience was tested by systematically changing the chromatographic settings. The approach described may be used for routine quantitative analysis.
Downloads
References
2. Dixit, R. P., and S. P. Puthli. 2009. “Oral Strip Technology: Overview and Future Potential.” Journal of Controlled Release 139(2):94–107. doi: 10.1016/j.jconrel.2009.06.014.
3. DrChandewar A.V, Dewani A. P. n.d. “Absorption Ratio Method For The Estimation Of Moxifloxacin Hcl & Ketorolac Tromethamine In Their Combined Dosage Form by Uv-Visible Spectroscopy.” International Standard Serial Number 3(7):21–26.
4. Genç, Lütfi, ErdenGüler, and Nahed Hegazy. 1997. “Film-Coated Enteric Tablet Formulation of Ketorolac Tromethamine.” Drug Development and Industrial Pharmacy 23(10):1007–11. doi: 10.3109/03639049709149154.
5. ICH, 2005. n.d. International Conference on Harmonisation (ICH) Q2 (R1): Validation of Analytical Procedures:
6. Issa, C., Bansal, K., Gupta, P. ,. n.d. “Simultaneous Determination of Ketorolac Tromethamine and Furosemide in Intestinal Perfusion Samples by Validated Reversed Phase High-Performance Liquid Chromatography. Ind. J. Pharm. Science.” 2005 67(6):672–76.
7. Mali, Audumbar, Santosh Jadhav, Rahul Gorad, Aamer Quazi, Ritesh Bathe, Manojkumar Patil, and Ashpak Tamboli. 2016. “Simultaneous UV Spectrophotometric Methods for Estimation of Cefixime Trihydrate and Ofloxacin in Bulk and Tablet Dosage Form.” Asian Journal of Pharmaceutical Research 6(2):100. doi: 10.5958/2231-5691.2016.00017.4.
8. Mirza, B.A., Kugalur, G. P. ,. n.d. “Formulation and Evaluation of Ketorolac Ocular Ph-Triggered in-Situ Gel. Int. J. Drug. Dev & Res.” 2(2):379–87.
9. Muhammad, A., Ullah Khanand, I.I.M., Naeem R., S. ,. n.d. “Stability Indicating HPLC Method for Simultaneous Determination of Moxifloxacin Hydrochloride and Ketorolac Tromethamine in Pharmaceutical Formulations. Quim Nova.” 1(6):200–209.
10. Pavani A., P. L. K. M. Rao. n.d. “Revalidation and Analytical Evaluation of Ketorolac Tromethamine By Hptlc Using Reflectance Scanning Densitometry.” IJRPC 2011 1(2):129–32.
11. Razzaq, Syed Naeem, Islam Ullah Khan, Muhammad Ashfaq, and Irfana Mariam. 2012. “Stability Indicating HPLC Method for Simultaneous Determination of Moxifloxacin Hydrochloride and Ketorolac Tromethamine in Pharmaceutical Formulations.” Química Nova 35(6):1216–21. doi: 10.1590/S0100-40422012000600028.
12. Squella, J. A., I. Lemus, J. C. Sturm, and L. J. Núñez-Vergara. 1997. “Voltammetric Behaviour of Ketorolac and Its HPLC-EC Determination in Tablets.” Analytical Letters 30(3):553–64. doi: 10.1080/00032719708001801.
13. Sumit, C., Patil, A. B. ,. 2009. “Formulation and Evaluation of Mouth Dissolving Tabletof Ketorolac Tromethamine for Pain Management by Using Superdisintegrants.” International Journal of ChemTech ResearchVol.1(No.4):1008–13.
14. Sunil, G., M. Jambulingam, S. Ananda Thangadurai, D. Kamalakannan, R. Sundaraganapathy, and C. Jothimanivannan. 2017. “Development and Validation of Ketorolac Tromethamine in Eye Drop Formulation by RP-HPLC Method.” Arabian Journal of Chemistry 10:S928–35. doi: 10.1016/j.arabjc.2012.12.031.
15. Yang, Jeon-Heon, Mi-Young Yun, Dae-Keun Kim, Mi-Jeong Kim, Young-ll Kim, Tae-Youl Kim, Kyu-Ho Yang, and Sang-Chul Shin. 2007. “Preparation and Evaluation of Ketorolac Tromethamine Gel Containing Genipin for Periodontal Diseases.” Archives of Pharmacal Research 30(7):871–75. doi: 10.1007/BF02978839.
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.